Nkarta Collaboration Achieves Cost Effective Manufacturing in Tight Timelines
Find out more about why Nkarta chose CCRM as its partner for clinical phase manufacturing of a natural killer cell product.
“We’ve found an ongoing partner [in CCRM]” – Dr. Ralph Brandenberger, SVP Technical Operations, Nkarta
DiscGenics Collaboration Successfully Develops Allogeneic Therapy to Enable Efficient Manufacturing
Learn about how DiscGenics worked with CCRM to establish a novel process.
“[The team] really helped us get to where we are today.” – Dr. Lara Ionescu Silverman, PhD, Senior Director, Research and Development, DiscGenics
Collaborative Relationship Allows Avectas to Accelerate the Translation of SOLUPORE™ into the Clinic
Learn how Avectas, a cell engineering technology company, worked with CCRM to develop a unique intracellular delivery platform to enable ex vivo cell-based therapies.
“[CCRM’s] culture and adaptive nature, flexibility and communication were excellent.” – Edel O’Toole, Senior Director Project & Vendor Management, Avectas
The Cystic Fibrosis (CF) Canada Program in Individualized Therapy (CFIT)
Learn how our team collaborated with an academic lab at SickKids to establish a bank of 100 patient-derived iPSC lines and isogenic controls.
“CCRM has shared valuable expertise with our team, benefiting the project overall.”
– Dr. Christine Bear, The Hospital for Sick Children
Process Development for Scaled-Up hESC/hiPSC Manufacturing
Read about an optimized 14-day manufacturing workflow that produces >1010 cells.
Manufacturing of Pluripotent Stem Cell-Derived Cardiomyocytes for Pre-Clinical Animal Studies
Find out how CCRM worked with a member of the local academic community to translate a cell therapy protocol from bench-scale to bioreactor.
Animal Component Free (ACF) Media Development for Cell Therapies
Understand how ACF media can achieve comparable performance to serum containing media.